| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |